switching between glp-1 agonists Mechanisms by which may exert beneficial effects on the Outcomes in GLP-1 RA-Experienced Patients

doi: 10.1111/jdi.14346 51 Petkovi-DabiJBiniICariBBoiLUmievi-ipkaSBednarukNet al

Oxidative RNA damage can impair protein translation, and damaged RNA can degrade prematurely, further impairs the synthesis of essential proteins ( Regarding mitochondrial dysfunction involved in AD pathophysiology, it includes disturbances in oxidative phosphorylation (OXPHOS), and impaired energy metabolism as well as excess generation of ROS, altered mitochondrial biogenesis, transport and dynamics ( Autophagy Autophagy is an important pathway in removing abnormal protein aggregates in cells and plays an essential role in protein homeostasis ( Diagnostics and treatments of AD Due to severe cognitive impairment in patients with advanced AD, the cost of treatment and care seriously affects economic development (78)

Increased FFA in the liver results in insulin resistance, hepatic glucose production, and pancreatic beta cell dysfunction [7]

This groundbreaking medication is shown to enhance therapeutic outcomes by delivering more pronounced reductions in both body weight and HbA1c levels than current pharmacotherapies

Adipose tissue reduction: Loss of intrahepatic and visceral fat with GLP-1RAs therapy is associated with decreased release of proinflammatory cytokines such as TNF-, IL-1, and IL-6 (Mehdi et al

Some GLP-1RAs devices have the ability to easily adjust the dose in response to intolerance (e.g